Cellular Reprogramming, Cloning and Stem Cells

Cellular Reprogramming Published by Mary Ann Liebert Inc. www.liebertpub.com/clo The primary journal for scientists and physicians who are engaged in mammalian cloning and therapeutic regenerative medicine. The only peer-reviewed journal focusing on all aspects of cloning from embryo to adult.
Audience	Scientists and physicians
Frequency	6 x pa
Editorial Focus	Covers all aspects of cloning along with the biology, culture, and differentiation of stem cells from all stages of development from germ cell to embryo and adult. The Journal also covers the culture and differentiation of stem cells in all stages of development. Topics include: Germline genetic engineering Molecular basis of pluripotency Oocyte maturation Nuclear transfer in fish Stem cells from cloned embryos
Editor(s) in Chief	Professor Sir Ian Wilmut OBE FRS FRSE Director - Centre for Regenerative Medicine, University of Edinburgh
Print Advertising Options	Adverts, Inserts & Supplements
Digital Advertising Options	Banners on website Banners on subscriber Table of Contents email alerts
Further Information	Heleen Vodégel Tel: +44 (0) 1875 825 700 hvodegel@impressmedia.com
Publisher	Cellular Reprogramming is owned and published by Mary Ann Liebert, Inc. Editorial headquarters: 140 Huguenot Street, New Rochelle, New York 10801, USA. Phone: +1 (914) 740-2100. Fax: +1 (914) 740-2101 www.liebertpub.com